Abstract
Isolation and comparison of uremic sera and urine and normal sera and urine were performed by gel permeation chromatography, anion exchange chromatography and reversed-phase high performance liquid chromatography. Two uremic middle molecular fractions (A and B) were obtained from uremic sera and urine and normal urine by gel permeation chromatography, but not from normal sera. The anion exchange chromatographic results of fraction A from different origins demonstrate that subfraction A-3 could be excreted in urine by healthy subject, but accumulated in uremic serum for renal failure of patient with uremia. After desalinization subfraction A-3 was analyzed by MALDI-TOF-MS. The results show that subfraction A-3 consists of six compounds with molecular weight 839, 873, 1007.94, 1106, 1680 and 2015 respectively. Finally, by reversed-phase high performance liquid chromatography, subfraction A-3 was further resolved into six independent fractions. Thus, the isolation and purification of six middle molecular compounds in subfraction A-3 came true by our method.
Similar content being viewed by others
References
Remond, V., Reta, D., Chen, H. et al., Uremic toxicity: the middle molecule hypothesis resisted, Seminars in Nephrol., 1994, 14(3): 205–218.
Remond, V., Reta, D., Psascale, V. et al., Middle molecules: toxicity and removal by hemodialysis and related strategies, Artif. Organs, 1995, 19(11): 1120–1125.
Gallice, P., Monti, J. P., Braguer, D. L. et al., Identification of an ascorbic acid metabolite among “uremic middle molecules”, Clin. Chem., 1990, 36(7): 1369–1372.
Abiko, T., Onodera, T., Sekino, H. et al., Apeptide isolation from the hemodialysate of a uremic patient with immunodeficiency inhibits lymphocyte stimulation, J. Appl. Biochem., 1981, 3: 562–569.
Wu Zhaolong, Liao Yutan, Cai Juhui et al., Biological activity of middle molecules from serum of patients with uremia, Chinese Journal of Pathophysiology, 1995, 11(1): 90–94.
Yuan Zhi, Zhang Ji, Zhao Fenzhi et al., Extraction and primary analysis of uremic middle molecular substance, Chem. J. Chin. Uni., 1989, 10(4): 401–405.
Chapman, G. V., Ward, R. A., Frrel, P. C. et al., Separation and quantification of “the middle molecules” in uremia, Kidney Int., 1980, 17: 82–88.
Chu Jiegen, Yuan Zhi, Mi Huaifeng et al., Isolation and analysis of middle molecular substances from uremic serum and normal urine, Science in China, Series B (in Chinese), 2000, 30(3): 250–255.
Fürst, P., Zimmerman, L., Bergstrom, J., Determination of endogenous middle molecules in normal and uremic body fluids, Clin. Nephrol., 1976, 5(4): 178–188.
Gibson, T. P., Matusk, E., Nelson, L. D. et al., Artifical kidneys and clearance calculations, Clin. Pharmacol. Ther., 1976, 20: 720–726.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chu, J., Liu, X., Yuan, Z. et al. Isolation and purification of uremic middle molecules by multi-step liquid chromatography. Sc. China Ser. B-Chem. 45, 225–231 (2002). https://doi.org/10.1360/02yb9030
Received:
Issue Date:
DOI: https://doi.org/10.1360/02yb9030